25 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18682685 | LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF | TRUONG, QUANGLONG N | 1615 | Non-Final OA | Feb 09, 2024 |
| 18291707 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS | WERTZ, ASHLEE ELIZABETH | 1612 | Non-Final OA | Jan 24, 2024 |
| 18291710 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | RONEY, CELESTE A | 1612 | Non-Final OA | Jan 24, 2024 |
| 18555130 | INFLUENZA-CORONAVIRUS COMBINATION VACCINES | ALAM, DANYAL HASSAN | 1672 | Non-Final OA | Oct 12, 2023 |
| 18555087 | RESPIRATORY VIRUS COMBINATION VACCINES | ALAM, DANYAL HASSAN | 1672 | Non-Final OA | Oct 12, 2023 |
| 18286705 | EPSTEIN-BARR VIRUS MRNA VACCINES | CHESTNUT, BARRY A | 1672 | Non-Final OA | Oct 12, 2023 |
| 18284395 | SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION | LEWIS, PATRICK T | 1691 | Non-Final OA | Sep 27, 2023 |
| 18284177 | PURIFICATION AND RECYCLING OF mRNA NUCLEOTIDE CAPS | CREWS, JARET JAMES | 1691 | Non-Final OA | Sep 26, 2023 |
| 18282097 | THERAPEUTIC USE OF SARS-COV-2 MRNA DOMAIN VACCINES | CHESTNUT, BARRY A | 1672 | Non-Final OA | Sep 14, 2023 |
| 18277346 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME | STEVENS, MARK V | 1613 | Non-Final OA | Aug 15, 2023 |
| 18036992 | RIBONUCLEIC ACID PURIFICATION | ZARA, JANE J | 1637 | Non-Final OA | May 15, 2023 |
| 18314980 | RESPIRATORY SYNCYTIAL VIRUS VACCINE | HILL, MYRON G | 1671 | Final Rejection | May 10, 2023 |
| 18161857 | METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS | GREENE, IVAN A | 1619 | Final Rejection | Jan 30, 2023 |
| 18012094 | LNP COMPOSITIONS COMPRISING MRNA THERAPEUTICS WITH EXTENDED HALF-LIFE | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Dec 21, 2022 |
| 18008139 | BACTERIAL STRAINS FOR DNA PRODUCTION | TINSLEY, BRENDAN THOMAS | 1634 | Non-Final OA | Dec 02, 2022 |
| 17925125 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF USING THE SAME FOR TREATING COVID-19 | LARA, CAROLINE MONSERRAT | 1633 | Non-Final OA | Nov 14, 2022 |
| 17925114 | RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION | LARA, CAROLINE MONSERRAT | 1633 | Non-Final OA | Nov 14, 2022 |
| 17924456 | LNP COMPOSITIONS COMPRISING AN MRNA THERAPEUTIC AND AN EFFECTOR MOLECULE | KELLY, ROBERT M | 1638 | Final Rejection | Nov 10, 2022 |
| 17796401 | RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS | HILL, MYRON G | 1671 | Final Rejection | Jul 29, 2022 |
| 17761863 | NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Mar 18, 2022 |
| 17615202 | EXPANDED T CELL ASSAY | IVICH, FERNANDO NMN | 1678 | Final Rejection | Nov 30, 2021 |
| 17277829 | STEROL ANALOGS AND USES THEREOF | MCDOWELL, BRIAN E | 1624 | Final Rejection | Mar 19, 2021 |
| 17276983 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | JOHNSON, ALLISON MARIE | 1638 | Non-Final OA | Mar 17, 2021 |
| 17255949 | PERSONALIZED CANCER VACCINE EPITOPE SELECTION | CANELLA, KAREN A | 1643 | Final Rejection | Dec 23, 2020 |
| 16482844 | RNA CANCER VACCINES | ANGELL, JON E | 1637 | Final Rejection | Aug 01, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial